| 000 | 01568 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513185026.0 | ||
| 264 | 0 | _c19990805 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.43.7.1621 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLopez-Ribot, J L | |
| 245 | 0 | 0 |
_aMultiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cJul 1999 |
||
| 300 |
_a1621-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xanalysis |
| 650 | 0 | 4 |
_aCandida albicans _xdrug effects |
| 650 | 0 | 4 |
_aCandidiasis _xdrug therapy |
| 650 | 0 | 4 |
_aCandidiasis, Oral _xdrug therapy |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aDrug Resistance, Multiple |
| 650 | 0 | 4 |
_aFluconazole _xpharmacology |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aPharyngeal Diseases _xdrug therapy |
| 650 | 0 | 4 | _aPhenotype |
| 700 | 1 | _aMcAtee, R K | |
| 700 | 1 | _aPerea, S | |
| 700 | 1 | _aKirkpatrick, W R | |
| 700 | 1 | _aRinaldi, M G | |
| 700 | 1 | _aPatterson, T F | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 43 _gno. 7 _gp. 1621-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.43.7.1621 _zAvailable from publisher's website |
| 999 |
_c10348548 _d10348548 |
||